Madrigal: The Easiest Money May Have Been Made

Madrigal has made three in-licensing deals since July 2025, picking up multiple potential MASH therapeutics. Read why MDGL ...

HELUS Pharma: Transitioning From Psychedelic Research To Late-Stage Clinical Neuroscience

HELUS Pharma has rebranded and moved to Nasdaq, signaling a shift toward late-stage clinical development and commercial focus ...
Frontiers

NSAIDs Beyond COX in Infection: Innate Sensing, Resolution, and Biofilm vs Planktonic Outcomes

Non-steroidal anti-inflammatory drugs (NSAIDs) are classically defined by cyclooxygenase (COX) inhibition, yet increasing evidence shows that many NSAIDs ...
The Manila Times

Ivim Health GLP-1 Weight Loss Program: Individualized Dosing, Pricing, and What Consumers Should Know in 2026

An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...
DMNews

A neurologist is warning that popular supplement stacks people take for brain health may actually be accelerating cognitive decline

A behavioral neurologist is seeing more patients whose carefully curated brain-health supplement stacks may be doing the opposite of what they intended — and the science behind why is something the ...
Frontiers

The Role of Pattern Recognition Receptors in linking Microbiota to Cancer Progression and Therapy

The interplay between host immunity, the microbiota, and cancer is a rapidly evolving area of immuno-oncology. An increasing body of evidence highlights the ...